• Join
  • Login
  • Contact

Search abstracts

Medication use evaluation: Ceftazidime-Avibactam combination therapy compared to Ceftazidime-Avibactam monotherapy

  • At: Seville (Spain) (2022)
  • Type: Digital
  • By: CHEN, Pei-chun (Taipei City Hospital Yangming Branch, China Taiwan)
  • Co-author(s): Ms Pei-chun Chen (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
    Mr. Kai-Hsiang Yang, Pharmacy (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
  • Abstract:

    Background information: The medicinal product Ceftazidime-Avibactam (Zavicefta®) is first-line therapy for the treatment of refractory infections caused by Gram-negative bacilli.

    Purpose: The purpose of this study was to evaluate the efficacy and adverse effects of Ceftazidime-Avibactam combined with other antibiotics and Ceftazidime-Avibactam..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses